EUCTR2012-003774-76-BE进行中（未招募）1 期
Perioperative ketorolac in high risk breast cancer patients with and without inflammation. A prospective randomized placebo-controlled trial. - KBC-trial
CUS0 个研究点目标入组 203 人开始时间: 2012年9月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 203
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Invasive Breast cancer with high risk of recurrence (presence of preop inflammation, triple negative histological status, lymph node invasion)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 150
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •Patients will be excluded if refusing or not able to follow any part of the protocol (preoperative screening, complete treatment or follow-up), in the case of history of cancer (from the breast of any another) in the past 2 years, in the case of planned non-curative surgery (preoperative confirmed T4 or M1 stage) and if the presence of a contraindication for ketorolac (or another of the drugs used in the standardized anesthetic protocol).
研究者
相似试验
已完成
3 期
Ketorolac in Breast Cancer SurgeryCurative Breast Cancer SurgeryInflammatory Positive/Negative StatusPre Surgical Incision AdministrationNCT01806259Université Catholique de Louvain203
已完成
1 期
Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid UseBreast ReductionBreast ReconstructionNCT04439396Carilion Clinic183
进行中（未招募）
1 期
ndersøgelse af ketorolac i den postoperative smertebehandling efter total knæalloplastikEUCTR2008-003180-39-DKOrtopædkirurgisk Afdeling Århus Universitetshospital90
已完成
不适用
Epirubicin/Paclitaxel/Cyclophosphamide-Methotrexate-Fluorouracil (E-T-CMF) as adjuvant chemotherapy in high-risk patients with operable breast cancerCancer - BreastBreast CancerACTRN12615000161527Hellenic Cooperative Oncology Group1,000
已完成
不适用
Investigation of the prognostic role of protein expression, mRNA levels, gene amplification and mutation of key cellular elements in patients with breast cancer treated with dose-dense sequential adjuvant chemotherapyCancer - BreastBreast CancerACTRN12616001043426Hellenic Cooperative Oncology Group1,060